Stay updated on Resmetirom Safety and Biomarkers Clinical Trial

Sign up to get notified when there's something new on the Resmetirom Safety and Biomarkers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Resmetirom Safety and Biomarkers Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.5.4 was added and Revision: v3.5.3 was removed. This indicates a minor site version update affecting only metadata, not the clinical trial details or study data presented on the page.
    Difference
    0.0%
    Check dated 2026-05-15T06:59:10.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page version/release label was updated from v3.5.2 to v3.5.3, indicating a site/module revision rather than a change to the ClinicalTrials.gov study record content.
    Difference
    0.0%
    Check dated 2026-04-24T05:51:36.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Added publication citation by Younossi et al. related to MAESTRO Resmetirom trials and updated the page revision from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:25:48.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Removed references to non-alcoholic fatty liver disease and related topics, including MedlinePlus Genetics.
    Difference
    0.1%
    Check dated 2026-04-02T15:25:10.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0; the prior revision, v3.4.3, is no longer displayed.
    Difference
    0.0%
    Check dated 2026-03-19T04:25:03.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T20:15:08.000Z thumbnail image

Stay in the know with updates to Resmetirom Safety and Biomarkers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Resmetirom Safety and Biomarkers Clinical Trial page.